investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

HAUSP inhibitors in p53-wild type and p53-mutant tumors

Wei Gu

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Wei Dai

New York University

New York, United States

Ning Kon

Columbia University

New York, United States

Wei Gu

Columbia University

New York, United States

Related projects

Shao-Cong Sun

Oncogenic Activation of Noncanonical NF-kB in B-cell Lymphomas

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Scott Kopetz

Tumor Heterogeneity and Acquired Resistance to EGFR Inhibition

Colorectum

Jacqueline Barlow

Characterization of replication-mediated DNA damage in B lymphocytes

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Dana Pe'Er

Integrative Cancer Genomics: Drivers, Pathways and Drugs

Colorectum

Joost Oppenheim

Studies of Receptor Interactions and Effects of Alarmins

Colorectum

John B Sunwoo

Enhancement of Natural Killer Cell Effector Functions

Non-Hodgkin lymphoma

Julie Secombe

Distinct Modes of Gene Regulation by KDM5

Colorectum

Kimmie Ng

Role of Vitamin D, Inflammation, and Energy Balance in Colorectal Cancer Survival

Colorectum

Pathology

Dirk P Dittmer

Regulation of the KSHV Latent Promoter

Non-Hodgkin lymphoma